Effective coatings on medical devices are becoming more and more necessary as infections linked to healthcare increase. These coatings are essential for keeping bacteria and microorganisms off of intricate surfaces like implants and surgical instruments.
With the help of these new coatings, medical professionals can treat their patients without causing them any major discomfort. Also, at the same time, there is a very low risk that the patient can develop any kind of infection during the treatment.
These days, many companies are trying to develop such medical device coatings. However, Hydromer is a leading company among them.
Reading guide
Antimicrobial coatings for enhanced infection control and safety
By using these new antimicrobial coatings, you can protect yourself from several viruses such as:
- coli
- MRSA
- Influenza
- Norovirus
- SARS-CoV-2
It is adaptable and may be used on a variety of surfaces, such as metals (such nitinol and stainless steel) and polymers (like polyamides, polycarbonates, and polyurethanes), as well as woven and non-woven textiles.
This innovative technology is non-leaching, making it safe for all environments, including class 3 implants used in chronic body areas. Its active components target microbes effectively while minimizing risk to human cells.
It provides skin protection for up to 48 hours and can stop biofilm growth for up to 365 days. Over the course of the device’s existence, it guarantees constant protection with its strong and secure antibacterial layer.
What developments and trends in medical devices may we expect in the near future?
Recent advancements in surgically implanted devices highlight a critical need for haemocompatibility, especially for those in constant contact with blood.
Surface modification is essential for achieving blood compatibility, and Hydromer’ Astute coating exemplifies this approach.
Astute, an antithrombogenic coating, has been effectively used for over 25 years on chronic implants and blood-contacting medical devices.
Read also: The Significance of Evaluating Poor Housing and Health Conditions
It features a non-leaching formula that combines an active antithrombogenic component with passive components to mimic the natural endothelial layer.
The active component disrupts the blood cascade mechanism, preventing platelet activation and thrombus formation, while the passive components inhibit blood component deposition.
This comprehensive approach ensures superior haemocompatibility without compromising performance over extended implantation periods.
In addition to haemocompatibility, the rise of miniaturized and minimally invasive procedures presents challenges such as reducing tissue trauma and infection risk. Hydromer addresses these needs with their Hydrophilic Coating, Assist.
This coating is designed to be lubricious and flexible, reducing friction and preventing particulate formation and delamination under high-stress conditions.
Assist employs a dual-function strategy to maintain device position and functionality, minimizing tissue damage and enhancing patient comfort during insertion and removal.
This innovation supports the evolving demand for smaller, high-quality medical devices, improving their safety and effectiveness.
What are the most prevalent problems that consumers are now having?
Medical product developers face a stringent regulatory environment, particularly under EU regulations where medical devices are tested by the European Medicines Agency (EMA) akin to drugs.
Hydromers’ Product Pathway Partnership team assists customers by optimizing application processes, fixture design, tooling, biocompatibility testing, and regulatory compliance.
They offer strategic guidance and a flexible approach to meet evolving regulatory demands for diverse devices, ensuring an effective and efficient route to market for their clients.
